This is wonderful news! But,
less than a week ago the MSM reported: Touted by Trump, hydroxychloroquine and remdesivir fail as coronavirus
therapy in preliminary studies I immediately labeled the story as fake news, which it was. It didn't take long to
NIH Dot Gov reports hospitalized patients with advanced COVID-19 and lung involvement who received remdesivir recovered faster than similar patients who received placebo, according to a preliminary data analysis from a randomized, controlled trial involving 1063 patients, which began on February 21. The trial (known as the Adaptive COVID-19 Treatment Trial, or ACTT), sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is the first clinical trial launched in the United States to evaluate an experimental treatment for COVID-19.